Variant Summary
- HGVS
- —
- Variant Type(s)
- missense_variant
- Evidence Items
- 5
Evidence Level Distribution
Level A: 2Level B: 2Level C: 1
Evidence Items
Showing CIViC evidence rows where gene = ERBB2 and variant = Mutation.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| A | Predictive | Supports | Sensitivity/Response | Lung Non-small Cell Carcinoma | Trastuzumab Deruxtecan | 4 |
| A | Predictive | Supports | Sensitivity/Response | Lung Non-small Cell Carcinoma | Zongertinib | 4 |
| B | Predictive | Supports | Sensitivity/Response | Breast Cancer | Neratinib | 4 |
| C | Predictive | Supports | Sensitivity/Response | Bladder Carcinoma | Platinum Compound | 3 |
| B | Predictive | Supports | Sensitivity/Response | Lung Non-small Cell Carcinoma | Pertuzumab,Trastuzumab | 2 |